[HTML][HTML] Acute macular neuroretinopathy associated with COVID-19 infection

JA David, GD Fivgas - American journal of ophthalmology case reports, 2021 - Elsevier
Purpose To report a case of bilateral acute macular neuroretinopathy (AMN) associated with
a COVID-19 infection. Observations A 22-year-old female was referred for evaluation of …

Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients

M Calderon-Dominguez, E Trejo-Gutierrez… - … Therapy-Nucleic Acids, 2022 - cell.com
Despite the extraordinary advances achieved to beat COVID-19 disease, many questions
remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors …

Direct RNA sequencing reveals SARS-CoV-2 m6A sites and possible differential DRACH motif methylation among variants

JHC Campos, JT Maricato, CT Braconi, F Antoneli… - Viruses, 2021 - mdpi.com
The causative agent of COVID-19 pandemic, SARS-CoV-2, has a 29,903 bases positive-
sense single-stranded RNA genome. RNAs exhibit about 150 modified bases that are …

Tissue factor links inflammation, thrombosis, and senescence in COVID-19

D Nguyen, HM Jeon, J Lee - Scientific reports, 2022 - nature.com
COVID-19 is a highly contagious respiratory infection caused by the SARS-CoV-2 virus. The
infected lung epithelial cells secrete a group of chemokines and cytokines, which triggers …

Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID‐19

JP Quintal Martinez… - Phytotherapy …, 2023 - Wiley Online Library
The SARS‐CoV‐2 outbreak has been one of the largest public health crises globally, while
thrombotic complications have emerged as an important factor contributing to mortality …

SARS-CoV-2 infection dysregulates host iron (Fe)-redox homeostasis (Fe-RH): role of Fe-redox regulators, ferroptosis inhibitors, anticoagulants, and iron-chelators in …

SAG Naidu, RA Clemens, AS Naidu - Journal of dietary …, 2023 - Taylor & Francis
Severe imbalance in iron metabolism among SARS-CoV-2 infected patients is prominent in
every symptomatic (mild, moderate to severe) clinical phase of COVID-19. Phase-I–Hypoxia …

Presence of a SARS-CoV-2 protein enhances amyloid formation of serum amyloid A

AK Jana, AB Greenwood… - The Journal of Physical …, 2021 - ACS Publications
A marker for the severeness and disease progress of COVID-19 is overexpression of serum
amyloid A (SAA) to levels that in other diseases are associated with a risk for SAA …

Association between COVID-19 diagnosis and coronary artery thrombosis: a narrative review

F Nappi, O Giacinto, O Ellouze, A Nenna… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

[HTML][HTML] Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial

L Davoodi, H Jafarpour, Z Oladi, Z Zakariaei… - IJC Heart & …, 2021 - Elsevier
Introduction Efficacious therapies are urgently required to tackle the coronavirus disease
2019 (COVID-19). This trial aims to evaluate the effects of atorvastatin in comparison with …

Gas6/TAM axis involvement in modulating inflammation and fibrosis in COVID-19 patients

M Rizzi, S Tonello, D D'Onghia… - International Journal of …, 2023 - mdpi.com
Gas6 (growth arrest-specific gene 6) is a widely expressed vitamin K-dependent protein that
is involved in many biological processes such as homeostatic regulation, inflammation and …